PetVivo Holdings Research and Development Expenses 2011-2024 | PETV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

PetVivo Holdings research and development expenses from 2011 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

PetVivo Holdings Research and Development Expenses 2011-2024 | PETV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

PetVivo Holdings research and development expenses from 2011 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$200.4B
Intuitive Surgical (ISRG)	$186.8B
Edwards Lifesciences (EW)	$44.1B
Alcon (ALC)	$41.8B
IQVIA Holdings (IQV)	$35.8B
IDEXX Laboratories (IDXX)	$33.8B
DexCom (DXCM)	$31.3B
Waters (WAT)	$21.9B
STERIS (STE)	$20.5B
SONOVA HOLDING (SONVY)	$19.7B
Hologic (HOLX)	$16.3B
Fresenius Medical Care AG KGaA (FMS)	$13.4B
Sysmex ADR (SSMXY)	$11.8B
Globus Medical (GMED)	$11.3B
Penumbra (PEN)	$9.3B
Masimo (MASI)	$9.1B
Glaukos (GKOS)	$8.3B
Teleflex (TFX)	$8.3B
Integer Holdings (ITGR)	$4.5B
PROCEPT BioRobotics (PRCT)	$4.2B
Inari Medical (NARI)	$3.2B
Veracyte (VCYT)	$3.2B
LivaNova (LIVN)	$2.6B
Nihon Kohden (NHNKY)	$2.4B
Tandem Diabetes Care (TNDM)	$2.4B
Elekta AB (EKTAY)	$2.1B
TransMedics (TMDX)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
RxSight (RXST)	$1.4B
Alphatec Holdings (ATEC)	$1.3B